Guidelines & Reports
AAP Guideline | Evaluation and treatment of children and adolescents with obesity
10 Jan, 2023 | 14:54h | UTCExecutive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity – Pediatrics
Commentaries:
Childhood obesity requires early, aggressive treatment, new guidelines say – NPR
New guidance: Use drugs, surgery early for obesity in kids – Associated Press
WHO Interim Guidance | Surveillance, case investigation and contact tracing for mpox (monkeypox)
10 Jan, 2023 | 14:45h | UTC
Recommendations for living donor kidney transplantation
10 Jan, 2023 | 14:39h | UTCRecommendations for living donor kidney transplantation – Nefrología
Consensus Paper | Antipsychotic medication deprescribing among adult patients with critical illness
10 Jan, 2023 | 14:37h | UTC
Commentary on Twitter
#CritCareExplore @SCCM Prescribing recommendations in ICU patients: limit antipsychotics to those with hyperactive delirium, at risk of harm to self/others or w/ care impacts. @n_jaworska@kiramakuk@KarlaKrewulak@dan_niven@lisa_burry@geetamehta0 @kmfiest https://t.co/73GUvrfJls pic.twitter.com/TbjbnGxD8Y
— Critical Care Explorations (@CritCareExplore) December 4, 2022
Expert Consensus | Clinical practice recommendations for primary hyperoxaluria
10 Jan, 2023 | 14:36h | UTC
ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults
9 Jan, 2023 | 14:59h | UTCSummary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults
WHO updates recommendations on HPV vaccination schedule
9 Jan, 2023 | 14:57h | UTCNews Release: WHO updates recommendations on HPV vaccination schedule – World Health Organization
Guideline: Human papillomavirus vaccines: WHO position paper, December 2022 – World Health Organization
Commentaries:
WHO supports 1-dose HPV vaccine strategy – CIDRAP
Commentary on Twitter
? WHO has revised its recommendations on possible schedules for human papillomavirus (#HPV) vaccines & now recommends:
?1 or 2-doses for girls & women aged 9-20
?2 doses with a 6-month interval for women 21+https://t.co/m0KZyH6sPR pic.twitter.com/W4PeS4raV9— World Health Organization (WHO) (@WHO) December 21, 2022
Guideline | Treatment of hypercalcemia of malignancy in adults
9 Jan, 2023 | 14:46h | UTCNews Release: Experts provide first framework for treating hypercalcemia of malignancy in adults – News Medical
ESC/AHA/ACC/WHF Joint Opinion | Randomized trials fit for the 21st century
9 Jan, 2023 | 14:44h | UTCCommentaries:
It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies – TCTMD
Commentary on Twitter
Together with @ACCinTouch @escardio & @worldheartfed, we are positioned to push, guide and support the remodeling of #RCTs for the 21st century. #RedesignRCTs
Read the joint statement in @circaha: https://t.co/hoypaSp10m pic.twitter.com/vwMGx0tksz
— AHA Science (@AHAScience) December 16, 2022
Consensus Guideline | Management of the perioperative patient on cannabis and cannabinoids
9 Jan, 2023 | 14:43h | UTC
Commentary on Twitter
All Patients Should be Screened for #Cannabis Use Before #Surgery, According to First U.S. Guidelines: https://t.co/QwAeh0cjFH @RAPMOnline @ShaliniShahMD @NarouzeMD @rakesh6282 @Drhaclarke @garyschwartzmd @ASALifeline pic.twitter.com/yPqaUauZMW
— ASRA Pain Medicine (@ASRA_Society) January 3, 2023
ASCO Guideline | Immunotherapy and targeted therapy for advanced gastroesophageal cancer
9 Jan, 2023 | 14:40h | UTC
ASCO Guideline | Immunotherapy and biomarker testing in recurrent and metastatic head and neck cancers
9 Jan, 2023 | 14:41h | UTCNews Release: ASCO Publishes New Guideline on Immunotherapy, Biomarker Testing in Advanced Head and Neck Cancer – ASCO Daily News
WHO manual on sugar-sweetened beverage taxation policies to promote healthy diets.
16 Dec, 2022 | 13:52h | UTCNews Release: WHO calls on countries to tax sugar-sweetened beverages to save lives – World Health Organization
Related:
M-A: Outcomes following taxation of sugar-sweetened beverages.
Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents – Pediatrics
Cutting back on sugar-sweetened beverages: What works? – Cochrane Library
Sugar-sweetened beverage taxes: Lessons to date and the future of taxation – PLOS Medicine
Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation
Sugar tax: why health experts want it but politicians and industry are resisting – The Guardian
Commentary on Twitter
Sugar is addictive and keeps you hooked on unhealthy drinks like sodas & energy drinks.
Break the cycle today for a healthier life! https://t.co/M1GQE4136I pic.twitter.com/06aVCYmeK5— World Health Organization (WHO) (@WHO) December 13, 2022
Updated Guidance | Acute, periprocedural and long-term antithrombotic therapy in older adults.
16 Dec, 2022 | 13:51h | UTCCommentary: Antithrombotic Therapy in Older Adults: Key Points – American College of Cardiology
Guideline | ADA 2023 Standards of Medical Care in Diabetes.
14 Dec, 2022 | 15:59h | UTCGuideline Homepage: ADA 2023 Standards of Medical Care in Diabetes – American Diabetes Association
Introduction: Standards of Medical Care in Diabetes—2023
Summary of Revisions: Standards of Medical Care in Diabetes—2023
- Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—2023
- Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023
- Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023
- Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
- Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023
- Glycemic Targets: Standards of Care in Diabetes—2023
- Diabetes Technology: Standards of Care in Diabetes—2023
- Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023
- Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023
- Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
- Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
- Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
- Older Adults: Standards of Care in Diabetes—2023
- Children and Adolescents: Standards of Care in Diabetes—2023
- Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2023
- Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
- Diabetes Advocacy: Standards of Care in Diabetes—2023
2022 ACR/EULAR classification criteria for giant cell arteritis.
16 Dec, 2022 | 13:39h | UTCNews Release: Updated: GCA Classification Criteria – European Alliance of Associations for Rheumatology
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.
15 Dec, 2022 | 13:52h | UTCBHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 – HIV Medicine
Pediatric intensive care ‘do not do’ recommendations in Spain: selection by Delphi method.
15 Dec, 2022 | 13:50h | UTC
Guidelines for reporting outcomes in trial reports: The CONSORT-Outcomes 2022 Extension.
15 Dec, 2022 | 13:45h | UTCGuidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension – JAMA (free for a limited period)
See also: Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension – JAMA (free for a limited period)
Commentary on Twitter
This report, the Consolidated Standards of Reporting Trials (CONSORT)–Outcomes 2022 extension, is a consensus statement on standards for reporting outcomes in clinical trial reports & contains recommendations to be integrated w the CONSORT 2010 statement. https://t.co/3cMgBmHtyE
— JAMA (@JAMA_current) December 14, 2022
Guidelines for reporting outcomes in trial protocols: The SPIRIT-Outcomes 2022 Extension.
15 Dec, 2022 | 13:46h | UTCGuidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension – JAMA (free for a limited period)
See also: Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension – JAMA (free for a limited period)
Commentary on Twitter
This Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-Outcomes 2022 extension of the SPIRIT 2013 statement provides 9 outcome-specific items that should be addressed in all trial protocols. https://t.co/OheGrTmcMh
— JAMA (@JAMA_current) December 13, 2022
Guideline | Postoperative pain management in non-traumatic emergency general surgery.
13 Dec, 2022 | 14:32h | UTC
EANM practice guideline for quantitative SPECT-CT.
13 Dec, 2022 | 14:26h | UTC
WHO Report signals increasing resistance to antibiotics in bacterial infections in humans.
12 Dec, 2022 | 12:52h | UTCCommentary: WHO report shows rising antibiotic resistance, need for better data – CIDRAP
Commentary on Twitter (thread – click for more)
New WHO report on #AntimicrobialResistance reveals very high levels of resistance in common bacteria frequently causing bloodstream infections in hospitals.
Infection prevention & control is critical to stop the spread and save lives.
More: https://t.co/8dGqw5KgZT pic.twitter.com/XGC2I7KbwB
— World Health Organization (WHO) (@WHO) December 9, 2022
2022 ACR/EULAR classification criteria for Takayasu arteritis.
12 Dec, 2022 | 12:50h | UTCNews Release: Classification criteria established for Takayasu arteritis – European Alliance of Associations for Rheumatology, EULAR
Consensus Statement | Management of thyroid eye disease.
12 Dec, 2022 | 12:51h | UTCCommentary: Worldwide Consensus on Thyroid Eye Disease? What Is In a Name? – Thyroid